Biovista patent for the use of tetracyclic pyrazinoindoles issued in the EU

Biovista is pleased to announce that its patent application for the use of tetracyclic pyrazinoindoles has issued in the EU.

This new patent (European patent No.: 2375900) has title “METHODS FOR TREATING MULTIPLE SCLEROSIS USING TETRACYCLIC PYRZINOINDOLES” was issued on March 2, 2016.